Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis

Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis

Bibliographic Details
Main Authors:	Jingxuan Lian, Jianfang Fu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Series:	Frontiers in Endocrinology
Subjects:	NAFLD type 2 diabetes mellitus pioglitazone meta-analysis prediabetes
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.840299/full

Similar Items

Pioglitazone - the forgotten drug with multidirectional action
by: Arkadiusz Aab, et al.
Published: (2023-04-01)

Possibilities of application a fixed combination of alogliptin and pioglitazone for type 2 diabetes mellitus treatment
by: M. V. Shestakova, et al.
Published: (2021-07-01)

A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
by: Roselle Arbas, et al.
Published: (2024-01-01)

Racial/ethnic and gender disparity in the severity of NAFLD among people with diabetes or prediabetes
by: Magda Shaheen, et al.
Published: (2023-02-01)

Prediabetes. Períodos de la diabetes mellitus
by: Iván Molina V.
Published: (2018-01-01)

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
by: Jieying Liu, et al.
Published: (2023-07-01)

Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis
by: Chin-Hsiao Tseng
Published: (2022-05-01)

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
by: Sun Ok Song, et al.
Published: (2012-10-01)

Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: A systematic review and meta-analysis
by: Qifan Zhong, et al.
Published: (2023-03-01)

Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study
by: Min-Hee Woo, et al.
Published: (2019-05-01)

Prediabetes tests in predicting risk of type 2 diabetes mellitus: a meta-analysis
by: L I Diaz-Trejo, et al.
Published: (2015-01-01)

Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis
by: Jingxuan Lian, et al.
Published: (2021-03-01)

The association between pioglitazone consumption and incidence of bladder cancer in type II diabetic patients: a systematic review and meta-analysis of observational studies
by: Pantea Ramezannezhad, et al.
Published: (2023-03-01)

Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population
by: Pratyush Kumar, et al.
Published: (2022-01-01)

Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus
by: Chin-Hsiao Tseng
Published: (2022-12-01)

Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis
by: Xiongfeng Pan, et al.
Published: (2021-05-01)

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
by: Yan H, et al.
Published: (2018-06-01)

Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
by: Hae Jin Kim, et al.
Published: (2022-09-01)

Lipoprotein (a) Level Among Patients with Type 2 Diabetes Mellitus and Prediabetes in Comparison with Healthy Controls
by: Barhav Issa Abdullah, et al.
Published: (2023-01-01)

Effect of pioglitazone, as antidiabetic agent, on atheroma regression in type 2 diabetic patients: a systematic review and meta-analysis
by: Antoine Fakhry AbdelMassih, et al.
Published: (2021-02-01)

Prevalence of Diabetes Mellitus and Prediabetes in Dalseong-gun, Daegu City, Korea
by: Jung-Eun Lee, et al.
Published: (2011-06-01)

Association of Snoring with Prediabetes and Type 2 Diabetes Mellitus: The Cardiovascular and Metabolic Diseases Etiology Research Center Cohort
by: So Mi Jemma Cho, et al.
Published: (2020-10-01)

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
by: Young Ki Lee, et al.
Published: (2013-12-01)

Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
by: Jiaying Yang, et al.
Published: (2023-01-01)

Commentary: Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis
by: Jie Wei
Published: (2021-09-01)

Effect of pioglitazone on nonalcoholic fatty liver disease in morbid obese patients; a randomized controlled trial
by: Masoud Sayadishahraki, et al.
Published: (2023-01-01)

Effect of Pioglitazone and Levo-Carnitine on Plasma Glucose, Insulin Resistance and Serum Adiponectin in Type 2 Diabetic Mice
by: Shahida Parveen
Published: (2014-06-01)

Effects of Resveratrol on pharmacokinetics and pharmacodynamics of Pioglitazone in Diabetic rats
by: Raju Devde1 , Narasimha Reddy Y2 , Sravanthi K3 , Abid Ali4 , Imran Khan5
Published: (2017-04-01)

Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study
by: Sunil Gupta, et al.
Published: (2015-01-01)

Cutaneous Manifestations of Diabetes Mellitus and Prediabetes
by: Maria Mendonça Sanches, et al.
Published: (2019-06-01)

Characteristics of the gut microbiome in patients with prediabetes and type 2 diabetes
by: Zewen Zhang, et al.
Published: (2021-03-01)

Efficacy and safety of pioglitazone for treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials
by: Guizhen Chang, et al.
Published: (2020-10-01)

Screening for diabetes and prediabetes: the newest communication opportunities
by: V.I. Velychko, et al.
Published: (2021-12-01)

Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
by: Pravesh Kumar Bundhun, et al.
Published: (2017-10-01)

The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and Pioglitazone
by: Yan-Rong Li, et al.
Published: (2021-08-01)

Nigella sativa supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
by: Saeede Saadati, et al.
Published: (2022-08-01)

Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
by: KM Erny-Albrecht, et al.
Published: (2009-03-01)

Periodontal parameters in prediabetes, type 2 diabetes mellitus, and non-diabetic patients
by: Mohammed ALASQAH, et al.
Published: (2018-08-01)

Association of Persistent, Incident, and Remittent Proteinuria With Stroke Risk in Patients With Diabetes Mellitus or Prediabetes Mellitus
by: Anxin Wang, et al.
Published: (2017-10-01)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
by: Schwartz S
Published: (2010-07-01)